Tyrosinase protects human melanocytes from ROS-generating compounds

Biochemical and Biophysical Research Communications

Volumn 305, Issue 2, 2003, Pages 250-256

  Perluigi, Marzia ^a   De Marco, Federico ^b   Foppoli, Cesira ^c   Coccia, Raffaella ^a   Blarzino, Carla ^a   Marcante, Maria Luisa ^b   Cini, Chiara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c CNR   (Italy)

Author keywords

Melanocyte; Reactive oxygen species; Salsolinol; Tetrahydroisoquinoline; Tetrahydropapaveroline; Tyrosinase

Indexed keywords

ENZYME INHIBITOR; GLUTATHIONE PEROXIDASE; MONOPHENOL MONOOXYGENASE; OXOGLUTARATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SALSOLINOL; TETRAHYDROISOQUINOLINE DERIVATIVE; TETRAHYDROPAPAVEROLINE;

ARTICLE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; MELANOCYTE; MITOCHONDRIAL RESPIRATION; POLYMERIZATION; PRIORITY JOURNAL;

EID: 0038367700     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00751-4     Document Type: Article

References (39)

1. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28:2000;1456-1462.
2. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:2002;47-95.
3. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222:1999;236-245.
4. Shackelford R.E., Kaufmann W.K., Paules R.S. Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med. 28:2000;1387-1404.
5. Ho E., Bray T.M. Antioxidants, NF-κB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 222:1999;205-213.
6. Kohen R., Gati I. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology. 148:2000;149-157.
7. Picardo M., Grammatico P., Roccella F., Roccella M., Grandinetti M., Del Porto G., Passi S. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J. Invest. Dermatol. 107:1996;322-326.
8. Valverde P., Manning P., Todd C., McNeil C.J., Thody A.J. Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion. Exp. Dermatol. 5:1996;247-253.
9. Wood J.M., Schallreuter K.U. Studies on the reactions between human tyrosinase superoxide anion hydrogen peroxide and thiols. Biochim. Biophys. Acta. 1074:1991;378-385.
10. Friedmann P.S., Gilchrest B.A. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J. Cell Physiol. 133:1987;88-94.
11. De Marco F., Perluigi M., Marcante M.L., Coccia R., Foppoli C., Blarzino C., Rosei M.A. Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells. Biochem. Pharmacol. 64:2002;1503-1512.
12. Dietrich R., Erwin V. Biogenic amine-aldehyde condensation products: tetrahydropapaverolines and tryptolines. Ann. Rev. Pharm. Toxicol. 20:1980;55-80.
13. Musshoff F., Daldrup T., Bonte W., Leitner A., Lesch O.M. Salsolinol and norsalsolinol in human urine samples. Pharmacol. Biochem. Behav. 58:1997;545-550.
14. Niwa T., Takeda N., Kaneda N., Hashizume Y., Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl tetrahydroisoquinoline in parkinsonian and human brains. Biochem. Biophys. Res. Commun. 144:1987;1084-1089.
15. McNaught K.S., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56:1998;921-933.
16. Dostert P., Strolin Benedetti M., Dordain G. Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J. Neural. Transm. 74:1988;61-74.
17. Rosei M.A., Mosca L. Production of melanin pigments by chemical and enzymatic oxidation of tetrahydroisoquinolines. Biochem. Mol. Biol. Int. 35:1995;1253-1259.
18. Mosca L., Blarzino C., Coccia R., Foppoli C., Rosei M.A. Melanins from tetrahydroisoquinolines. Spectroscopic characteristics, scavenging activity and redox transfer properties. Free Radic. Biol. Med. 24:1998;161-167.
19. De Marco F., Di Lonardo A., Venuti A., Marcante M.L. Interferon inhibition of neoplastic phenotype in cell lines harbouring human papillomavirus sequences. J. Biol. Regul. Homeost. Agents. 5:1991;65-70.
20. Gerlier D., Thomasset N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods. 94:1986;5763-5769.
21. Calogero A., Timmer-Bosscha H., Schraffordt Koops H., Tiebosch A.T., Mulder N.H., Hospers G.A. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes. Br. J. Cancer. 83:2000;184-187.
22. Dondi E., Pattyn E., Lutfalla G., Van Ostade X., Uze G., Pellegrini S., Tavernier J. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase. J. Biol. Chem. 276:2001;47004-47012.
23. Ernster L. DT-Diaphorase. Eastbrook R.W., Pullman M.E. Methods in Enzymology. vol. 10:1967;309-317 Academic Press, New York.
24. Ursini F., Maiorino M., Brigelius-Flohe R., Aumann K.D., Roveri A., Schomburg D., Flohe L. Diversity of glutathione peroxidases. Methods Enzymol. 252:1995;38-53.
25. Park L.C., Zhang H., Sheu K.F., Calingasan N.Y., Kristal B.S., Lindsay J.G., Gibson G.E. Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J. Neurochem. 72:1999;1948-1958.
26. Spitz D.R., Oberley L.W. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal. Biochem. 179:1989;8-18.
27. Winder A.J., Harris H. New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. Eur. J. Biochem. 198:1991;317-326.
28. Fuller B.B., Drake M.A., Spaulding D.T., Chaudhry F. Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J. Invest. Dermatol. 114:2000;268-276.
29. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
30. Urabe K K., Aroca P., Tsukamoto K., Mascagna D., Palumbo A., Prota G., Hearing V.J. The inherent cytotoxicity of melanin precursors: a revision. Biochim. Biophys. Acta. 1221:1994;272-278.
31. Passi S., Picardo M., Nazzaro-Porro M. Comparative cytotoxicity of phenols in vitro. Biochem. J. 245:1987;537-542.
32. Slominski A., Moellmann G., Kuklinska E. L-Tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells. Pigment. Cell Res. 2:1989;109-116.
33. G. Karg, G. Odh, A. Wittbjer, E. Rosengren, H. Rorsman H., Hydrogen peroxide as an inducer of elevated tyrosinase level in melanoma cells, J. Invest. Dermatol. 100 (1993) 209-213S.
34. Nappi A.J., Vass E., Collins M.A. Contrasting effects of catecholic and O-methylated tetrahydroisoquinolines on hydroxyl radical production. Biochim. Biophys. Acta. 1434:1999;64-73.
35. Schallreuter K.U., Wood J.M. Free radical reduction in the human epidermis. Free Radic. Biol. Med. 6:1989;519-532.
36. Yohn J.J., Norris D.A., Yrastorza D.G., Buno I.J., Leff J.A., Hake S.S., Repine J.E. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J. Invest. Dermatol. 97:1991;405-409.
37. Jimenez-Cervantes C., Martinez-Esparza M., Perez C., Daum N., Solano F., Garcia-Borron J.C. Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J. Cell Sci. 114:2001;2335-2344.
38. Yang F., Boissy R.E. Effects of 4-tertiary butylphenol on the tyrosinase activity in human melanocytes. Pigment. Cell Res. 12:1999;237-245.
39. Storch A., Kaftan A., Burkhardt K., Schwarz J. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855:2000;67-75.